| Colleen Verwer Auger, OT | |
|
39 Hospital Center Cmns, Hilton Head Island, SC 29926-2837 | |
| (843) 689-2233 | |
| (843) 689-2234 |
| Full Name | Colleen Verwer Auger |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 36 Years |
| Location | 39 Hospital Center Cmns, Hilton Head Island, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124205810 | NPI | - | NPPES |
| 3687 | Other | NC | NC LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 3687 (North Carolina) | Secondary |
| 225XH1200X | Occupational Therapist - Hand | 4121 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaufort Orthopaedic Sports And Spine Center Llc | 1355301771 | 36 |
News Archive
NeuroVive Pharmaceutical AB (publ) (STO:NVP), a leading mitochondrial medicine company, has signed a collaboration agreement with Isomerase Therapeutics to develop the molecules that were recently acquired from Biotica.
This study analyzed data for about 6,400 patients who had heart attacks to compare black and white patients across a range of characteristics (demographic, socioeconomic status, social factors, lifestyle factors, medical history, clinical presentation, health status and depression).
A new study from the Multimodal Neuroimaging for AD Diagnosis study, which is a prospective study implemented at the National Center for Geriatrics and Gerontology, provides that hypometabolism in the medial prefrontal areas is specifically associated with Alzheimer's disease-related nutritional problems, and decrease in fat mass may have a key role. This study is published in the Journal of Alzheimer's Disease.
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
OPKO Health, Inc. and The Scripps Research Institute today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
› Verified 2 days ago
| Provider Name | Beaufort Orthopaedic Sports And Spine Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982765160 PECOS PAC ID: 1355301771 Enrollment ID: O20041012000064 |
News Archive
NeuroVive Pharmaceutical AB (publ) (STO:NVP), a leading mitochondrial medicine company, has signed a collaboration agreement with Isomerase Therapeutics to develop the molecules that were recently acquired from Biotica.
This study analyzed data for about 6,400 patients who had heart attacks to compare black and white patients across a range of characteristics (demographic, socioeconomic status, social factors, lifestyle factors, medical history, clinical presentation, health status and depression).
A new study from the Multimodal Neuroimaging for AD Diagnosis study, which is a prospective study implemented at the National Center for Geriatrics and Gerontology, provides that hypometabolism in the medial prefrontal areas is specifically associated with Alzheimer's disease-related nutritional problems, and decrease in fat mass may have a key role. This study is published in the Journal of Alzheimer's Disease.
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
OPKO Health, Inc. and The Scripps Research Institute today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colleen Verwer Auger, OT 39 Hospital Center Cmns, Hilton Head Island, SC 29926-2837 Ph: (843) 689-2233 | Colleen Verwer Auger, OT 39 Hospital Center Cmns, Hilton Head Island, SC 29926-2837 Ph: (843) 689-2233 |
News Archive
NeuroVive Pharmaceutical AB (publ) (STO:NVP), a leading mitochondrial medicine company, has signed a collaboration agreement with Isomerase Therapeutics to develop the molecules that were recently acquired from Biotica.
This study analyzed data for about 6,400 patients who had heart attacks to compare black and white patients across a range of characteristics (demographic, socioeconomic status, social factors, lifestyle factors, medical history, clinical presentation, health status and depression).
A new study from the Multimodal Neuroimaging for AD Diagnosis study, which is a prospective study implemented at the National Center for Geriatrics and Gerontology, provides that hypometabolism in the medial prefrontal areas is specifically associated with Alzheimer's disease-related nutritional problems, and decrease in fat mass may have a key role. This study is published in the Journal of Alzheimer's Disease.
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
OPKO Health, Inc. and The Scripps Research Institute today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
› Verified 2 days ago
Jenna Marie Greene, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 24 Bethea Dr, Hilton Head Island, SC 29926 Phone: 843-682-7301 | |
Dr. Jana Cason, DHSC, OTR/L, FAOTA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 Bow Cir, Hilton Head Island, SC 29928 Phone: 843-256-4381 Fax: 855-694-1010 | |
Mrs. Bernadette T Luce, O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 30 Spartina Point Dr, Hilton Head Island, SC 29926 Phone: 478-318-9746 | |
Mrs. Leslie Kay Rogers, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 60 Main St, Suite H, Hilton Head Island, SC 29926 Phone: 843-342-9000 Fax: 843-342-9044 | |
Mrs. Sharon Marley Brown, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8 Hospital Center Blvd, Suite 250, Hilton Head Island, SC 29926 Phone: 843-342-5700 Fax: 843-342-5702 | |
Ms. Kristin Denise Perilli, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 39 Hospital Center Cmns, Hilton Head Island, SC 29926 Phone: 843-689-2233 Fax: 843-689-2234 |